Pembrolizumab (Keytruda) - Oncology Nurse Advisor

Pembrolizumab (Keytruda)

Slideshow

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

  • Slide

This slideshow reviews pembrolizumab (Keytruda), indicated for the treatment of unresectable or metastatic melanoma, metastatic non-small cell lung cancer (NSCLC), and recurrent or metastatic head and neck squamous cell carcinoma (HNSCC).

Table of Contents

Slide 4: Dosage and Administration
Slide 12: Cautions, Effects, and Interactions
Slide 19: What to Tell Your Patient
Slide 27: Reference

Next hm-slideshow in Slides